RECRUITING

MISP 60528 Pneumococcal Vaccination

Description

This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.

Study Overview

Study Details

Study overview

This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.

Response to Guideline-concordant Pneumococcal Vaccination Strategy in Cardiac Transplant Candidates and Recipients

MISP 60528 Pneumococcal Vaccination

Condition
Heart Transplant Infection Prevention
Intervention / Treatment

-

Contacts and Locations

Bronx

Montefiore Medical Center, Infectious Diseases, Bronx, New York, United States, 10467

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 or over
  • * Either undergoing evaluation for heart transplant (with or without LVAD receipt), or having received a heart transplant
  • * Receiving a dose of PCV15 or PPSV23 (or both sequentially) concordant with AST guidelines
  • * Infants and children under age 18
  • * Subjects without the capacity to consent
  • * Pregnancy
  • * Already up to date on pneumococcal vaccination or declining vaccination

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Montefiore Medical Center,

Vagish Hemmige, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center

Study Record Dates

2025-07